ARCHIVES

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 7 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Breast Cancer Coalition Delivers 175,000 Letters To Congress; IL Cancer Council Has New Name

October 11, 1991

Grassley Pledges More Congressional Oversight of CME.

March 14, 2008

Cullen Credits Staff With Success Of STCP, Strong Prevention Program a NCI

May 19, 1989

CDC Offers Funds For 5-A-Day Program; CDC PA Available

May 14, 1999

Harold Varmus To Receive National Medal Of Science; Gates Foundation Hires Klausner.

May 17, 2002

Henderson Heads HHS Preparedness Office; NCI Awards $22M Southern Cohort Study.

November 9, 2001